Courage for a Brave New World: Medical Genetics, Evolution, and a Roman Catholic Approach to Human Gene Transfer
Online Access
http://digital.library.duq.edu/u?/etd,90094Abstract
PhDHealth Care Ethics
McAnulty College and Graduate School of Liberal Arts
This dissertation answers the question, "How does one know what forms of human gene transfer are morally permissible from a Catholic perspective, within an evolutionary worldview, and in the context of genetic medicine?" This is a study of moral methodology applied to a particular form of genetic engineering (i.e., human gene transfer, HGT) in the Catholic tradition. It includes a brief survey of the state of the art of HGT, a survey that concludes at the end of 2004. It defines HGT as well as identifies accomplishments and obstacles of the technology. The study also examines biological evolution and how this process relates biological information (e.g., genes) to a concept of normality. Here, particular attention is paid to variation and adaptation. Next, the study places the normative question of HGT in the context of genetic medicine by exploring the philosophy of medicine. It connects interpretations of HGT to the goals of medicine by examining and expanding the four-quadrant division of HGT (i.e., therapy, enhancement, somatic cell, and germ-line cell interventions). To formulate a Catholic perspective, this study examines the hermeneutic framework of theological anthropology by describing the five Christian themes of creation, sin, incarnation, redemption, and eschatology. Moreover, the Catholic perspective includes specific approaches of moral theology and Christian ethics. Here, this study examines natural law ethical theory at the metaethical and normative levels, in particular proportionalism. The study concludes by identifying key ethical issues involved in making a moral judgment on HGT interventions. These are organized under deontological, axiological, and ethological issues. Deontological issues include issues of obedience to civil law and regulations, Church teaching, and professional codes and moratoria. Axiological issues include issues involved in determining the rightness or wrongness of actions by reference to value or disvalue (e.g., life, health, social justice, etc.). Finally, ethological issues include those associated with acting with integrity of conscience (responsibly forming a conscience) as well as integrity of character (acting in a manner consistent with virtue).
Dissertation
Date
2007-07-25Identifier
oai:digital.library.duq.edu:etd/90094http://digital.library.duq.edu/u?/etd,90094
Copyright/License
Abstract only: no access to PDF file by author request.Related items
Showing items related by title, author, creator and subject.
-
Al-muwakabah al-Shar'iyah li mu'tayat al-handasah al-wirathíyahAbu Ghuddah, 'Abd al-Sattar (2016-01-08)This paper was submitted to the symposium held by the Islamic Organization for Medical Sciences (IOMS) in Kuwait during the period 13-15 October 1998 on genetics. The paper presents detailed juristic answers for different questions raised by the applications of genetic engineering such as prenatal diagnostic testing especially in case of endogamous marriage, gene therapy, genetic privacy and selective abortion.
-
Privacy-preserving genomic testing in the clinic: A model using HIV treatmentMclaren P.J.; Raisaro J.L.; Aouri M.; Rotger M.; Ayday E.; Bartha I.; Delgado M.B.; Vallet Y.; Günthard H.F.; Cavassini M.; et al. (Nature Publishing Group, 2018-04-12)Purpose:The implementation of genomic-based medicine is hindered by unresolved questions regarding data privacy and delivery of interpreted results to health-care practitioners. We used DNA-based prediction of HIV-related outcomes as a model to explore critical issues in clinical genomics.Methods:We genotyped 4,149 markers in HIV-positive individuals. Variants allowed for prediction of 17 traits relevant to HIV medical care, inference of patient ancestry, and imputation of human leukocyte antigen (HLA) types. Genetic data were processed under a privacy-preserving framework using homomorphic encryption, and clinical reports describing potentially actionable results were delivered to health-care providers.Results:A total of 230 patients were included in the study. We demonstrated the feasibility of encrypting a large number of genetic markers, inferring patient ancestry, computing monogenic and polygenic trait risks, and reporting results under privacy-preserving conditions. The average execution time of a multimarker test on encrypted data was 865 ms on a standard computer. The proportion of tests returning potentially actionable genetic results ranged from 0 to 54%.Conclusions:The model of implementation presented herein informs on strategies to deliver genomic test results for clinical care. Data encryption to ensure privacy helps to build patient trust, a key requirement on the road to genomic-based medicine. © 2015 American College of Medical Genetics and Genomics.